LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.78 | 771.67 | 2704 | 3499 | 0.7727 | 0.7770 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.55 | 771.67 | 4375 | 6829 | 0.6406 | 0.7360 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.00 | 771.67 | 1595 | 1585 | 1.0060 | 1.0115 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.55 | 771.67 | 2516 | 3196 | 0.7871 | 0.7796 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.67 | 771.67 | 3462 | 5155 | 0.6715 | 0.7295 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.33 | 771.67 | 4169 | 6392 | 0.6522 | 0.7385 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.94 | 771.67 | 1045 | 1045 | 0.9999 | 0.9995 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.78 | 771.67 | 1440 | 1459 | 0.9865 | 0.9706 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.66 | 771.67 | 1889 | 2141 | 0.8821 | 0.8367 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.33 | 771.67 | 2368 | 2939 | 0.8056 | 0.7880 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.22 | 771.67 | 2995 | 4299 | 0.6966 | 0.7285 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.44 | 771.67 | 3218 | 4738 | 0.6791 | 0.7252 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.89 | 771.67 | 3751 | 5541 | 0.6769 | 0.7436 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.11 | 771.67 | 3986 | 5941 | 0.6709 | 0.7465 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.49 | 771.67 | 869 | 867 | 1.0014 | 1.0171 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.71 | 771.67 | 956 | 956 | 0.9996 | 0.9975 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.16 | 771.67 | 1113 | 1138 | 0.9776 | 0.9209 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.56 | 771.67 | 1265 | 1280 | 0.9878 | 0.9667 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.22 | 771.67 | 1714 | 1741 | 0.9843 | 0.9732 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.44 | 771.67 | 1795 | 1910 | 0.9394 | 0.9066 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.89 | 771.67 | 2005 | 2397 | 0.8362 | 0.7928 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.11 | 771.67 | 2131 | 2675 | 0.7966 | 0.7618 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.00 | 771.67 | 2852 | 3884 | 0.7342 | 0.7518 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.99 | 771.67 | 4853 | 7690 | 0.6311 | 0.7408 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 771.67 | 4682 | 7256 | 0.6452 | 0.7465 | MN20160304_L01 | C03 |